According to survey data recently published in the journal Cannabis and Cannabinoid Research, almost three in four licensed health care professions in Washington state are supporting the use of medicinal marijuana over opioids for patients who suffer from chronic pain.
The survey was conducted by researchers with the University of Washington School of Nursing who surveyed a random sampling of actively licensed health care professionals legally permitted to provide medical cannabis authorizations in the state of Washington.
The results found that of eligible respondents, 72 percent agreed with the statement, “Medical marijuana should be used to reduce the use of opioids for non-cancer pain.”
Sixty-three percent of respondents also agreed, “The DEA should reclassify marijuana so that it is no longer a schedule I [prohibited] drug [under federal law].”
Over 80 percent of respondents had also expressed interest in receiving additional medical training with respect to cannabis.
NORML Deputy Director Paul Armentano commented, “These opinions are consistent with those of other medical professionals throughout the United States, most of whom possess attitudes toward cannabis’ therapeutic efficacy that are incongruent with the federal government’s ‘Flat Earth’ position that marijuana is a substance without any accepted medical value.”
The survey’s authors stated, “Patients expect their clinician to provide information on the effects, risks, and benefits of cannabis. Health care professionals must be prepared to meet their expectations and to do so within the letter of the law. Now more than ever, a rational approach to medical cannabis is needed to assure that unforeseen consequences are mitigated while responsibly promoting the use of cannabis for medically appropriate symptoms and conditions.”
